Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22b1673638db2579a1be473ac139f6c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e482dae8f4f767034149618ed513151 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a235d5ea68d2fb026a0478e87aa13525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_65f43003a51deffe0b1d8103ac12a584 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0fee919b25f67af4712af4db7b3381f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65038 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6503 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 |
filingDate |
2003-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3dd8a2fab08b6395ac75352f02893b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_608dbe2e1346bfd51c3d8df33cb96964 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22ab26122fbdb7105004dc733f5ff9e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd669c1f1000c9ec8ddc9a5e6c87b092 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36514a90d630bead00a27802a10e1864 |
publicationDate |
2004-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004043932-A1 |
titleOfInvention |
Ophthalmic compositions for treating ocular hypertension |
abstract |
This invention relates to potent potassium channel blocker indazole derivatives or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8173679-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008516929-A |
priorityDate |
2002-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |